Jason Douglas Wilson is CFO at REATA PHARMACEUTICALS INC (RETA). They have made 25 open-market trades across 1 company since 2019, most recently 2019-12-16.
CIK 0001662395
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RETA | 13,750 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2019-12-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RETA | SELL | 2019-12-16 | 2019-12-17 | $203.34 | $1.2M | -5.0% | +0.5% | -39.6% |
| RETA | SELL | 2019-12-16 | 2019-12-17 | $203.29 | $2.1M | -5.0% | +0.5% | -39.6% |
| RETA | SELL | 2019-10-17 | 2019-10-21 | $170.00 | $1.7M | +14.3% | +18.1% | +18.1% |
| RETA | SELL | 2019-10-15 | 2019-10-15 | $146.12 | $2.1M | +23.6% | +28.2% | +27.3% |
| RETA | SELL | 2019-10-14 | 2019-10-15 | $129.54 | $5.5M | +23.6% | +28.2% | +27.3% |
| RETA | SELL | 2019-08-15 | 2019-08-16 | $72.81 | $420K | -5.4% | +12.0% | +164.7% |
| RETA | SELL | 2019-08-15 | 2019-08-16 | $72.64 | $283K | -5.4% | +12.0% | +164.7% |
| RETA | SELL | 2019-07-15 | 2019-07-17 | $84.64 | $339K | +6.5% | -10.0% | +87.7% |
| RETA | SELL | 2019-07-15 | 2019-07-17 | $84.46 | $574K | +6.5% | -10.0% | +87.7% |
| RETA | SELL | 2019-06-17 | 2019-06-19 | $83.54 | $668K | +10.1% | +0.2% | +2.0% |
| RETA | SELL | 2019-06-17 | 2019-06-19 | $83.64 | $243K | +10.1% | +0.2% | +2.0% |
| RETA | SELL | 2019-05-15 | 2019-05-17 | $89.91 | $360K | +1.8% | -7.0% | -20.0% |
| RETA | SELL | 2019-05-15 | 2019-05-17 | $89.91 | $360K | +1.8% | -7.0% | -20.0% |
| RETA | SELL | 2019-04-15 | 2019-04-16 | $83.70 | $310K | -1.3% | +10.6% | +3.3% |
| RETA | SELL | 2019-04-15 | 2019-04-16 | $83.81 | $671K | -1.3% | +10.6% | +3.3% |
| RETA | SELL | 2019-03-19 | 2019-03-21 | $93.47 | $5.2M | -0.1% | -16.0% | -8.2% |
| RETA | SELL | 2019-03-19 | 2019-03-21 | $93.50 | $2.6M | -0.1% | -16.0% | -8.2% |
| RETA | SELL | 2019-03-18 | 2019-03-19 | $95.11 | $153K | -8.0% | -15.5% | -8.7% |
| RETA | SELL | 2019-03-15 | 2019-03-19 | $94.04 | $527K | -8.0% | -15.5% | -8.7% |
| RETA | SELL | 2019-03-15 | 2019-03-19 | $93.62 | $374K | -8.0% | -15.5% | -8.7% |
| RETA | SELL | 2019-02-15 | 2019-02-19 | $85.44 | $342K | +9.5% | +5.8% | +1.1% |
| RETA | SELL | 2019-02-05 | 2019-02-06 | $80.00 | $240K | +7.4% | +16.3% | +3.7% |
| RETA | SELL | 2019-01-31 | 2019-02-04 | $80.00 | $560K | +10.7% | +18.4% | +9.3% |
| RETA | SELL | 2019-01-15 | 2019-01-16 | $71.15 | $569K | +1.5% | +18.7% | +13.4% |
| RETA | SELL | 2019-01-07 | 2019-01-09 | $72.04 | $2.9M | +7.2% | +20.1% | +23.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.